TY - JOUR
T1 - Elevated plasma glucagon in amyotrophic lateral sclerosis
AU - Hubbard, Richard W.
AU - Will, A. D.
AU - Peterson, G. W.
AU - Sanchez, A.
AU - Gillan, W. W.
AU - Tan, S. A.
N1 - This study shows an abnormality in glucagon levels that may explain the glucose intolerance, abnormal insulin reactions, and abnormal plasma amino acid levels seen in amyotrophic lateral sclerosis (ALS). We randomly administered two test meals, differing only in protein source (soy versus casein) at least 1 week apart and measured fasting and postprandial bloods for glucagon, insulin, and glucose levels in 11 ALS patients.
PY - 1992/8
Y1 - 1992/8
N2 - This study shows an abnormality in glucagon levels that may explain the glucose intolerance, abnormal insulin reactions, and abnormal plasma amino acid levels seen in amyotrophic lateral sclerosis (ALS). We randomly administered two test meals, differing only in protein source (soy versus casein) at least 1 week apart and measured fasting and postprandial bloods for glucagon, insulin, and glucose levels in 11 ALS patients. With the soy test meal, glucagon levels were elevated in all ALS patients compared with controls: at fasting (237 ± 111 versus 108 ± 46 pg/ml, p < 0.01) and 2 hour (389 ± 94 versus 133 ± 68 pg/ml, p < 0.001), and 2 hours postprandial (379 ± 75 versus 108 ± 53 pg/ml, p < 0.001). Glucagon levels after the casein test meal were also significantly elevated. Insulin was elevated by both test meals. Casein produced significant glucose intolerance.
AB - This study shows an abnormality in glucagon levels that may explain the glucose intolerance, abnormal insulin reactions, and abnormal plasma amino acid levels seen in amyotrophic lateral sclerosis (ALS). We randomly administered two test meals, differing only in protein source (soy versus casein) at least 1 week apart and measured fasting and postprandial bloods for glucagon, insulin, and glucose levels in 11 ALS patients. With the soy test meal, glucagon levels were elevated in all ALS patients compared with controls: at fasting (237 ± 111 versus 108 ± 46 pg/ml, p < 0.01) and 2 hour (389 ± 94 versus 133 ± 68 pg/ml, p < 0.001), and 2 hours postprandial (379 ± 75 versus 108 ± 53 pg/ml, p < 0.001). Glucagon levels after the casein test meal were also significantly elevated. Insulin was elevated by both test meals. Casein produced significant glucose intolerance.
UR - http://www.scopus.com/inward/record.url?scp=0026722550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026722550&partnerID=8YFLogxK
U2 - 10.1212/wnl.42.8.1532
DO - 10.1212/wnl.42.8.1532
M3 - Article
C2 - 1641148
SN - 0028-3878
VL - 42
SP - 1532
EP - 1534
JO - Neurology
JF - Neurology
IS - 8
ER -